Haleon PLC Sponsored ADR $HLN Shares Acquired by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC lifted its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 12.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 95,992 shares of the company’s stock after purchasing an additional 10,581 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Haleon were worth $992,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Hanson & Doremus Investment Management raised its holdings in Haleon by 234.1% during the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock worth $25,000 after purchasing an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC lifted its holdings in Haleon by 135.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after acquiring an additional 1,491 shares during the period. Banque Transatlantique SA acquired a new position in shares of Haleon during the 1st quarter worth $27,000. Ransom Advisory Ltd acquired a new position in shares of Haleon during the 1st quarter worth $31,000. Finally, Deutsche Bank AG raised its stake in Haleon by 267.8% in the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock valued at $32,000 after purchasing an additional 2,276 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Performance

HLN opened at $9.48 on Friday. The firm has a market capitalization of $42.22 billion, a P/E ratio of 24.31, a price-to-earnings-growth ratio of 2.69 and a beta of 0.20. The stock’s 50 day moving average price is $9.41 and its two-hundred day moving average price is $9.99. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 12-month low of $8.71 and a 12-month high of $11.42.

Haleon Increases Dividend

The company also recently disclosed a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were given a $0.0555 dividend. The ex-dividend date was Friday, August 15th. This represents a dividend yield of 190.0%. This is an increase from Haleon’s previous semi-annual dividend of $0.05. Haleon’s dividend payout ratio is 28.21%.

Analysts Set New Price Targets

HLN has been the subject of several recent analyst reports. The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a report on Wednesday, September 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. Barclays downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Finally, Wall Street Zen cut Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.